FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

This oversubscribed Series A funding round was led by General Catalyst with additional investment from new investors, British ...

Data privacy experts are urging consumers to be proactive about protecting their data on the site. Here's how to delete yours ...

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intensity Therapeutics, Inc. (INTS – Research ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...

Equities researchers at Jones Trading began coverage on shares of Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) in a ...

Stock analysts at Lifesci Capital cut their FY2025 earnings per share estimates for Astria Therapeutics in a research report ...

Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cognition Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Researchers from Mass General Brigham developed olfactory tests—in which participants sniff odor labels that have been placed on a card—to assess people’s ability to discriminate, identify and ...

Frederic L.W.V.J. Schaper, MD, PhD , director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at ...